14-74048055-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025057.3(BBOF1):c.773C>A(p.Thr258Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000292 in 1,610,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025057.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBOF1 | NM_025057.3 | c.773C>A | p.Thr258Asn | missense_variant | 7/12 | ENST00000394009.5 | NP_079333.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BBOF1 | ENST00000394009.5 | c.773C>A | p.Thr258Asn | missense_variant | 7/12 | 2 | NM_025057.3 | ENSP00000377577.3 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000106 AC: 26AN: 245508Hom.: 0 AF XY: 0.0000975 AC XY: 13AN XY: 133298
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1458506Hom.: 0 Cov.: 31 AF XY: 0.0000221 AC XY: 16AN XY: 725294
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | The c.773C>A (p.T258N) alteration is located in exon 7 (coding exon 7) of the BBOF1 gene. This alteration results from a C to A substitution at nucleotide position 773, causing the threonine (T) at amino acid position 258 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at